Home Sitemap Contact us Accessibility Statement Top of the page

Oncology in focus

We work hard to ease the way for people with cancer throughout their treatment journey and to offer choice and scientific based information to oncology specialists.


We focus on supporting the NHS in managing conditions like cancer. Our aim is to work in partnership to develop joined-up care through Joint Working projects, to improve patient outcomes and enhance patient experience, and also to offer value for money. That might be through medicines optimisation, quality improvement, pathway redesign or improvement, innovation or identifying cost efficiencies.

Our medicines treat cancer and associated conditions like chemotherapy-induced neutropenia and breakthrough cancer pain.

Cancer is a major cause of morbidity and mortality throughout the world. In the UK, every two minutes someone is diagnosed with cancer.1

In our portfolio of generic medicines, we have treatments for a wide range of cancer types. Our Specialty lines focus on chemotherapy-induced neutropenia, acute promyelocytic leukaemia and metastatic breast cancer.

Lonquex®▼ (lipegfilgrastim)

Trisenox® (arsenic trioxide)

Myocet® (liposomal doxorubicin)

Support for healthcare professionals

Support for healthcare professionals
  • For factual, scientific-based information about Lonquex®, Trisenox® and Myocet® contact Teva’s Medical Information Service via e-mail medinfo@tevauk.com or call 0207 540 7117
  • Further information, including Prescribing Information for Lonquex®, Trisenox® and Myocet® is available from the respective pages linked to above
  • You can also request a visit from the Key Account Manager here

Joint Working

Joint Working

Our Joint Working projects help the NHS and healthcare professionals deliver improved patient outcomes. Our Joint Working projects are available on our Joint Working pages.

To discuss potential Joint Working opportunities with Teva within oncology you can contact us and a representative from Teva will be in touch. 

1 http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence#heading-Zero [accessed 31/03/16].

2 Lonquex® (lipegfilgrastim) Summary of Product Characteristics.

3 Trisenox® (arsenic trioxide) Summary of Product Characterisitics.

4 Myocet® (doxorubicin) Summary of Product Characterisitics.

Teva UK Limited

Are you a healthcare professional?

To access this section of the Teva UK Limited website you need to be a member of the healthcare profession because the materials included in this area of our website are specifically prepared for that audience only.
To understand why that is - please visit: Working in a regulated environment

Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.

I am a